Advanced search
Publication Cover
International Journal of Hyperthermia Volume 37, 2020 - Issue 1
Submit an article Journal homepage
2,769
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience

Giovanni Brandia Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Alessandro Rizzoa Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyCorrespondence[email protected]
View further author information
,
Filippo Gustavo Dall’Olioa Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Cristina Felicanib Department of Organ Insufficiency and Transplantation, S. Orsola-Malpighi Hospital, Bologna, ItalyView further author information
,
Giorgio Ercolanic Department of Medical and Surgical Sciences-DIMEC, S. Orsola-Malpighi Hospital, Alma Mater Studiorum-University of Bologna, Bologna, ItalyView further author information
,
Matteo Cesconc Department of Medical and Surgical Sciences-DIMEC, S. Orsola-Malpighi Hospital, Alma Mater Studiorum-University of Bologna, Bologna, ItalyView further author information
,
Giorgio Fregaa Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Simona Tavolarid Center of Applied Biomedical Research, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Andrea Pallonia Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Stefania De Lorenzoa Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Francesca Abbatia Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Veronica Mollicaa Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
,
Angela Dalia Riccia Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyView further author information
&
Carla Serrab Department of Organ Insufficiency and Transplantation, S. Orsola-Malpighi Hospital, Bologna, ItalyView further author information
 show all
Pages 479-485 | Received 29 Jan 2020, Accepted 25 Apr 2020, Published online: 12 May 2020

Citations (57)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Lisha Li, Dandan Yu, Jinru Yang, Fangyuan Zhang, Dejun Zhang, Zhenyu Lin, Menglan Zhai, Jing Wang, Tao Zhang & Lei Zhao. (2024) Significant response to pembrolizumab plus lenvatinib in Epstein–Barr-virus-associated intrahepatic cholangiocarcinoma: a case report. Cancer Biology & Therapy 25:1.
Read now
Xia Yan, Li-Ping Zhuang, Zhou-Yu Ning, Peng Wang & Zhi-Qiang Meng. (2022) Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis. Expert Review of Gastroenterology & Hepatology 16:1, pages 81-88.
Read now
Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola & Giovanni Brandi. (2021) Radiofrequency ablation for intrahepatic cholangiocarcinoma: a tool upon the path of integrative modalities?. Expert Review of Gastroenterology & Hepatology 15:11, pages 1239-1240.
Read now
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) Ivosidenib in IDH-mutant cholangiocarcinoma: where do we stand?. Expert Review of Precision Medicine and Drug Development 6:3, pages 217-224.
Read now
Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico & Giovanni Brandi. (2021) FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue. Expert Review of Gastroenterology & Hepatology 15:5, pages 567-574.
Read now
Alessandro Rizzo & Giovanni Brandi. (2021) Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer. Expert Review of Gastroenterology & Hepatology 15:5, pages 547-554.
Read now
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) Recent advances of immunotherapy for biliary tract cancer. Expert Review of Gastroenterology & Hepatology 15:5, pages 527-536.
Read now
Tao Wang, Jinfu Zhang, Wanxiang Wang, Xianwei Yang, Junjie Kong, Shu Shen & Wentao Wang. (2020) Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis. Cancer Management and Research 12, pages 11015-11029.
Read now
Dariuosh Rahban, Mahtab Doostan & Ali Salimi. (2020) Cancer Therapy; Prospects for Application of Nanoparticles for Magnetic-Based Hyperthermia. Cancer Investigation 38:8-9, pages 507-521.
Read now

Articles from other publishers (48)

Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean‐Frédéric Blanc, Lorraine Blaise, Alix Demory, Gisele Nkontchou, Véronique Grando, Marianne Ziol, Pierre Nahon, Nathalie Ganne‐Carrié, Arthur Petit, Olivier Seror, Olivier Sutter & Jean‐Charles Nault. (2024) Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma. Liver International 44:6, pages 1363-1372.
Crossref
Julaluck Promsorn, Panjaporn Naknan, Aumkhae Sookprasert, Kosin Wirasorn, Jarin Chindaprasirt, Attapol Titapun, Piyapharom Intarawichian & Mukesh Harisinghani. (2024) Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma. Heliyon 10:7, pages e28805.
Crossref
Yueting Sun, Baoxian Liu, Hui Shen, Yi Zhang, Ruiying Zheng, Jiaming Liu, Hanliang Hu, Xiaoyan Xie & Guangliang Huang. (2024) Cox model risk score to predict survival of intrahepatic cholangiocarcinoma after ultrasound-guided ablation. Abdominal Radiology 49:5, pages 1653-1663.
Crossref
Gregory Woodhead, Sean Lee, Lucas Struycken, Daniel Goldberg, Jack Hannallah & Shamar Young. (2024) Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma. Life 14:2, pages 217.
Crossref
Fusheng Liu, Yingyi Liu, Xingyuan Hao, Bin Liu, Xuyun Yan, Anling Li, Ping Jiang, Weihua Huang, Song-Mei Liu & Yufeng Yuan. (2024) Altered bile metabolome and its diagnostic potential for biliopancreatic malignancies. Clinica Chimica Acta 554, pages 117777.
Crossref
Lorenza Rimassa, Giovanni Brandi, Monica Niger, Nicola Normanno & Davide Melisi. (2023) Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement. Critical Reviews in Oncology/Hematology 192, pages 104146.
Crossref
Elishama N. Kanu, Kristen E. Rhodin, Sabran J. Masoud, Austin M. Eckhoff, Alex J. Bartholomew, Thomas C. Howell, Jiayin Bao, Nicholas T. Befera, Charles Y. Kim, Dan G. Blazer, Sabino Zani, Daniel P. Nussbaum, Peter J. Allen & Michael E. Lidsky. (2023) Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablation. Journal of Surgical Oncology 128:8, pages 1329-1339.
Crossref
Wen-Hui Luo, Shao-Jun Li & Xue-Feng Wang. (2023) Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature. World Journal of Gastrointestinal Oncology 15:11, pages 2033-2040.
Crossref
Reto Bale & Timothy M. Pawlik. (2023) Treatment of intrahepatic cholangiocarcinoma: evidence for the role of percutaneous ablation. Hepatoma Research.
Crossref
Héloïse Bourien, Chiara Carlotta Pircher, Boris Guiu, Angela Lamarca, Juan W Valle, Monica Niger & Julien Edeline. (2023) Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?. Cancers 15:17, pages 4217.
Crossref
Georgios Charalampopoulos, Roberto Iezzi, Maria Tsitskari, Argyro Mazioti, Olympia Papakonstantinou, Alexis Kelekis, Nikolaos Kelekis & Dimitrios Filippiadis. (2023) Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma. Medicina 59:7, pages 1186.
Crossref
Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Guilin Nie, Yuan Tian, Jiong Lu & Bei Li. (2023) Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review. BMC Cancer 23:1.
Crossref
Mackenzie Owen, Mina S. Makary & Eliza W. Beal. (2023) Locoregional Therapy for Intrahepatic Cholangiocarcinoma. Cancers 15:8, pages 2384.
Crossref
Andrea Laurenzi, Giovanni Brandi, Federica Greco, Enrico Prosperi, Andrea Palloni, Matteo Serenari, Giorgio Frega, Matteo Ravaioli, Alessandro Rizzo & Matteo Cescon. (2023) Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?. Langenbeck's Archives of Surgery 408:1.
Crossref
Wei Zhang, Chu Luo, Zun-Yi Zhang, Bi-Xiang Zhang & Xiao-Ping Chen. (2023) Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review. Frontiers in Immunology 13.
Crossref
Joanna Kefas, John Bridgewater, Arndt Vogel, Alexander Stein & John Primrose. (2023) Adjuvant therapy of biliary tract cancers. Therapeutic Advances in Medical Oncology 15, pages 175883592311637.
Crossref
I. V. Savchenko, V. V. Breder, I. S. Stilidi, K. K. Laktionov, N. E. Kudashkin, A. V. Egorova & S. V. Chulkova. (2022) Second line drug therapy for biliary cancer. Meditsinskiy sovet = Medical Council:22, pages 136-147.
Crossref
Yifan Wang, Mario Strazzabosco & David C. Madoff. (2022) Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?. Current Oncology Reports 24:12, pages 1741-1750.
Crossref
Tingjie Wang, Chuanrui Xu, Dan Xu, Xiaofei Yang, Yaxin Liu, Xiujuan Li, Zihang Li, Ningxin Dang, Yi Lv, Zhijing Zhang, Lei Li & Kai Ye. (2022) Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma. Frontiers in Genetics 13.
Crossref
Xiao-xue Zhang, Hong-bin Ma, Tie-hua Li, Bin Huang, Ning-yang Jia & Yan Meng. (2022) Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma. Clinical and Translational Oncology 25:3, pages 731-738.
Crossref
Meng-Ye He, Fei-Fei Yan, Kai-Li Cen & Peng Shen. (2022) Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World Journal of Clinical Cases 10:32, pages 11889-11897.
Crossref
Jie Zhao, Yongzhong Guo, Wenzhou Ding, Guoyong Han, Chuanwei Jiang, Chao Yang, Yuanchang Hu, Long Zhang, Chen Wu, Ming Ni, Xiangyi Kong, Tian Huang, Chuanyong Zhang & Yongxiang Xia. (2022) Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study. Frontiers in Oncology 12.
Crossref
Buwen Zhang & Weiyun Yao. (2022) Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients. World Journal of Surgical Oncology 20:1.
Crossref
Feiyu Li, Yong Jiang, Liyong Jiang, Qingbin Li, Xiangyu Yan, Songhan Huang, Ji Chen, Shuai Yuan, Yingda Fu & Jun Liu. (2022) Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Qingshun Zhu, Shengyong Zhai, Enkang Ge, Lei Li, Xuguang Jiao, Jinqiu Xiong, Guangxu Zhu, Yuanyuan Xu, Jianjun Qu & Zhengjiang Wang. (2022) Intrahepatic cholangiocarcinoma with gastric metastasis misdiagnosed as primary gastric cancer: A case report and literature review. Frontiers in Oncology 12.
Crossref
Haipeng Yu, Yan Xu, Wei Gao, Mei Li, Ji’an He, Xiaoqian Deng & Wenge Xing. (2022) Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer. Frontiers in Oncology 12.
Crossref
Jianzheng Wang, Baiwen Zhang, Xiaojiao Cheng, Qingli Li, Huifang Lv, Caiyun Nie, Beibei Chen, Weifeng Xu, Jing Zhao, Yunduan He, Shuiping Tu & Xiaobing Chen. (2022) Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors. Journal of Oncology 2022, pages 1-8.
Crossref
Gun Ha Kim, Pyeong Hwa Kim, Jin Hyoung Kim, Pyo-Nyun Kim, Hyung Jin Won, Yong Moon Shin & Sang Hyun Choi. (2021) Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. European Radiology 32:2, pages 1205-1215.
Crossref
Gonzalo Sapisochin, Tommy Ivanics & Julie Heimbach. (2022) Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?. Hepatology 75:2, pages 455-472.
Crossref
Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić & Vladimir Dugalić. (2022) Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI. Current Oncology 29:2, pages 698-723.
Crossref
Dmitry Yakovlev, Artem Shiryaev, Dina Farrakhova, Tatiana Savelieva, Kanamat Efendiev, Maxim Loshchenov, Gleb Zhemerikin, Marine Amouroux, Christian Daul, Walter Blondel, Igor Reshetov & Victor Loschenov. (2022) Comparison of the Capabilities of Spectroscopic and Quantitative Video Analysis of Fluorescence for the Diagnosis and Photodynamic Therapy Control of Cholangiocellular Cancer. Photonics 9:2, pages 65.
Crossref
Maria A. Gonzalez-Carmona, Christian Möhring, Robert Mahn, Taotao Zhou, Alexandra Bartels, Farsaneh Sadeghlar, Maximilian Bolch, Annabelle Vogt, Dominik J. Kaczmarek, Dominik J. Heling, Leona Dold, Jacob Nattermann, Vittorio Branchi, Hanno Matthaei, Steffen Manekeller, Jörg C. Kalff, Christian P. Strassburg, Raphael U. Mohr & Tobias J. Weismüller. (2022) Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy. Scientific Reports 12:1.
Crossref
A. A. Gritskevich, B. N. Gurmikov, T. P. Baitman, A. N. Shipilova, A. A. Paichadze & A. V. Chzhao. (2021) Cholangiocarcinogenesis and targeted therapy for cholangiocarcinoma. Meditsinskiy sovet = Medical Council:20, pages 101-109.
Crossref
Sha Yang, Huapeng Lin & Jianning Song. (2021) Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis. Cancer Cell International 21:1.
Crossref
Matthias P. Fabritius, Najib Ben Khaled, Wolfgang G. Kunz, Jens Ricke & Max Seidensticker. (2021) Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma—Role of Interventional Radiology. Journal of Clinical Medicine 10:23, pages 5574.
Crossref
Karolin J. Paprottka, Franziska Galiè, Michael Ingrisch, Tobias Geith, Harun Ilhan, Andrei Todica, Marlies Michl, Jonathan Nadjiri & Philipp M. Paprottka. (2021) Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors. Cancers 13:21, pages 5399.
Crossref
Rocio I.R. Macias, Maria J. Monte, Maria A. Serrano, Jesús M. González-Santiago, Isabel Martín-Arribas, André L. Simão, Rui E. Castro, Javier González-Gallego, José L. Mauriz & Jose J.G. Marin. (2021) Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging 13:19, pages 23416-23434.
Crossref
Hee Ho Chu, Jin Hyoung Kim, Yong Moon Shin, Hyung Jin Won & Pyo-Nyun Kim. (2021) Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes. American Journal of Roentgenology 217:2, pages 426-432.
Crossref
Hang Li, Li Chen, Guang-Yu Zhu, Xijuan Yao, Rui Dong & Jin-He Guo. (2021) Interventional Treatment for Cholangiocarcinoma. Frontiers in Oncology 11.
Crossref
Alessandro Rizzo. (2021) Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors. Medicina 57:5, pages 458.
Crossref
Alessandro Rizzo, Angela Dalia Ricci & Giovanni Brandi. (2021) PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer. Cancers 13:3, pages 558.
Crossref
Tianyu Wu, Xiaoqing Jiang, Xin Zhang, Bodeng Wu, Bin Xu, Xiaoliu Liu, Lei Zheng & Yu Wang. (2021) Intrahepatic Cholangiocarcinoma: State of the Art of FGFR Inhibitors. Cancer Control 28, pages 107327482198931.
Crossref
Eliza W. Beal, Jordan M. Cloyd & Timothy M. Pawlik. (2020) Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles. Journal of Clinical Medicine 10:1, pages 104.
Crossref
Makoto Ueno, Masafumi Ikeda, Takashi Sasaki, Fumio Nagashima, Nobumasa Mizuno, Satoshi Shimizu, Hiroki Ikezawa, Nozomi Hayata, Ryo Nakajima & Chigusa Morizane. (2020) Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results. BMC Cancer 20:1.
Crossref
Alessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, Giorgio Frega, Andrea Palloni, Valeria Relli, Massimiliano Salati, Elisabetta Fenocchio, Annamaria Massa, Massimo Aglietta & Giovanni Brandi. (2020) Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures. Cancers 12:11, pages 3256.
Crossref
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari & Giovanni Brandi. (2020) PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?. Medicines 7:9, pages 54.
Crossref
Tian Shen, Shanhua Zheng, Lei Geng, Zhengtao Liu, Jun Xu, Bingyi Lin, Junjie Qian & Shusen Zheng. (2020) Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review. Technology in Cancer Research & Treatment 19, pages 153303382097970.
Crossref
Alessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, Giorgio Frega, Andrea Palloni, Rachele Pagani, Simona Tavolari, Mariacristina Di Marco & Giovanni Brandi. (2020) Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges. Cancer Control 27:1, pages 107327482098301.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.